Resultados de procura - Cheng‐Yuan Peng

Limitar resultados
  1. 1
    Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy

    Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy por Cheng‐Yuan Peng, Rong‐Nan Chien, Yun–Fan Liaw

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

    Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. por Min Xu, Kelly-Ann Sheppard, Cheng‐Yuan Peng, Amy S. Yee, Helen Piwnica‐Worms

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis

    Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis por Y. C. Chen, Cheng‐Yuan Peng, Wen‐Juei Jeng, Rong‐Nan Chien, Yun–Fan Liaw

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder

    Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder por Kuan‐Pin Su, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Jane Pei‐Chen Chang, Carmine M. Pariante

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection

    Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection por Qing Wang, Cheng‐Yuan Peng, Min Yang, Fengqi Huang, Xuzhuo Duan, Shaowen Wang, Huitao Cheng, Huirong Yang, Huihong Zhao, Qiwei Qin

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C

    Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C por Sheng‐Hung Chen, Yufen Li, Hsueh‐Chou Lai, Jung‐Ta Kao, Cheng‐Yuan Peng, Po‐Heng Chuang, Wen‐Pang Su, I‐Ping Chiang

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels

    Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels por Kuan‐Pin Su, Shih‐Yi Huang, Cheng‐Yuan Peng, Hsueh‐Chou Lai, Chieh‐Liang Huang, Yi-Chih Chen, Katherine J. Aitchison, Carmine M. Pariante

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning

    Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning por Runmin Wei, Jingye Wang, Xiaoning Wang, Guoxiang Xie, Yixing Wang, Hua Zhang, Cheng‐Yuan Peng, Cynthia Rajani, Sandi A. Kwee, Ping Liu, Wei Jia

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial

    Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial por Kuan‐Pin Su, Hsueh‐Chou Lai, Hui-Ting Yang, Wen-Pang Su, Cheng‐Yuan Peng, Jane Pei‐Chen Chang, Hui-Chih Chang, Carmine M. Pariante

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Increased Incidence of Gastrointestinal Cancers Among Patients With Pyogenic Liver Abscess: A Population-Based Cohort Study

    Increased Incidence of Gastrointestinal Cancers Among Patients With Pyogenic Liver Abscess: A Population-Based Cohort Study por Hsueh‐Chou Lai, Che‐Chen Lin, Ken‐Sheng Cheng, Jung‐Ta Kao, Jen‐Wei Chou, Cheng‐Yuan Peng, Shih‐Wei Lai, Pei‐Chun Chen, Fung‐Chang Sung

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

    Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis por Ira M. Jacobson, Eric Lawitz, Paul Y. Kwo, Christophe Hézode, Cheng‐Yuan Peng, Anita Y. M. Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis

    New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis por Hung‐Wei Wang, Cheng‐Yuan Peng, Hsueh-Chou Lai, Wen-Pang Su, Chia‐Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen, Wei‐Fan Hsu, Guan‐Tarn Huang

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

    Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents por Wei‐Fan Hsu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Po‐Heng Chuang, Sheng‐Hung Chen, Hung‐Yao Chen, Hung‐Wei Wang, Guan‐Tarn Huang, Cheng‐Yuan Peng

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

    Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir por Chien‐Hung Chen, Chuan-Mo Lee, Hsueh‐Chou Lai, Tsung‐Hui Hu, Wen-Pang Su, Sheng‐Nan Lu, Chia‐Hsin Lin, Chao‐Hung Hung, Jing‐Houng Wang, Mei–Hsuan Lee, Cheng‐Yuan Peng

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

    Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study por Yun–Fan Liaw, M. Raptopoulou‐Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng‐Yuan Peng, Robert P. Myers, Robert S. Brown, Lennox J. Jeffers, Naoky Tsai, Jolanta Białkowska, Shijie Tang, S. P. Beebe, Elizabeth Cooney

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan

    Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan por Chen‐Hua Liu, Ming‐Lung Yu, Cheng‐Yuan Peng, Tsai‐Yuan Hsieh, Yi‐Hsiang Huang, Wei‐Wen Su, Pin‐Nan Cheng, Chih‐Lin Lin, Gin‐Ho Lo, Chi‐Yi Chen, Jyh‐Jou Chen, Qian Ma, C. Brooks-Rooney, Jia‐Horng Kao

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion

    Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion por Hung‐Chih Yang, Chi‐Ling Chen, Yueh-Chi Shen, Cheng‐Yuan Peng, Chun‐Jen Liu, Tai–Chung Tseng, Tung‐Hung Su, Wan‐Long Chuang, Ming‐Lung Yu, Chia‐Yen Dai, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

    Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection por Paul Y. Kwo, Edward Gane, Cheng‐Yuan Peng, Brian L. Pearlman, John M. Vierling, Lawrence Serfaty, Marı́a Buti, Stephen D. Shafran, Paul Stryszak, Lin Li, Jacqueline Gress, Stuart Black, Frank J. Dutko, Michael Robertson, Janice Wahl, Lisa Lupinacci, Eliav Barr, Barbara Haber

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

    2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations por Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population

    2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population por Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: